ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,434.43
1.68%
Dow Jones
39,765.64
0.00%
US Dollar vs MXN
18.92813
-0.39%
Brent Oil
80.275
-0.40%
Bitcoin
61,341.68
1.19%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
14/08/202407:00InvestorsHub NewsWireAvant Technologies Unveils AI-Powered Healthcare Infrastructure to Deliver Intelligent Healthcare SolutionsUSOTC:AVAIAvant Technologies Inc (QB)
14/08/202407:00GlobeNewswire Inc.Quadient Recognized as a Major Player for First Time in IDC MarketScape for Worldwide Accounts Payable Automation Software for Midmarket and Small BusinessesEU:QDTQUADIENT SA
14/08/202407:00GlobeNewswire Inc.SignalPET Elevates Leadership Team and Announces Strategic Expansion
14/08/202407:00Business WireLa RAMQ élargit sa couverture provinciale pour inclure le Dexcom G7, offrant ainsi le système de SCG de nouvelle génération à un plus grand nombre de QuébécoisNASDAQ:DXCMDexCom Inc
14/08/202407:00GlobeNewswire Inc.Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates Expected Timing for NDA Filing of Anaphylm™NASDAQ:AQSTAquestive Therapeutics Inc
14/08/202407:00GlobeNewswire Inc.Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:NAUTNautilus Biotechnology Inc
14/08/202407:00Business WireSimilarweb Appoints Hubspot CMO Kipp Bodnar to Board of DirectorsNYSE:SMWBSimilarweb Ltd
14/08/202407:00GlobeNewswire Inc.Hinge Bio, Inc. Chief Scientific Officer, Daniel Capon, Ph.D., to Present its GEM-DIMER™ Platform Technology at the University of Oxford, Kennedy Institute of Rheumatology’s Annual Translational Research Conference
14/08/202407:00GlobeNewswire Inc.Avalon’s Laboratory Services MSO to Launch Sales of Proprietary FDA-Registered External Male Catheter DeviceNASDAQ:ALBTAvalon GloboCare Corporation
14/08/202407:00GlobeNewswire Inc.Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-ZrNASDAQ:MNPRMonopar Therapeutics Inc
14/08/202407:00Business WireAffiliate of Paceline Equity Partners Provides Financing Facility to Promise Confections
14/08/202407:00Business WireCyberArk to Present at Upcoming Investor ConferencesNASDAQ:CYBRCyberArk Software Ltd
14/08/202407:00Business WireShift4 Announces Payment Partnership with the Indiana PacersNYSE:FOURShift4 Payments Inc
14/08/202407:00GlobeNewswire Inc.Melissa Data Quality Services Now Available in the Stripe Marketplace
14/08/202407:00GlobeNewswire Inc.Calibre Scientific Acquires Greyhound Chromatography, a UK Provider of Analytical Standards and Chromatography Consumables
14/08/202407:00Business WireConcentra Adds Behavioral Health to Telemedicine Service for Workers’ Compensation
14/08/202407:00Business WireAccutar Biotechnology Receives FDA Fast Track Designation for AC699 in ER+ / HER2- Breast Cancer
14/08/202406:58Alliance NewsAlliance NewsTOP NEWS: Playtech in talks to sell Snaitech to Flutter EntertainmentLSE:FLTRFlutter Entertainment Plc
14/08/202406:57Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JBLUJetBlue Airways Corporation
14/08/202406:57PR Newswire (US)In recognition of its market-leading capabilities QNB Group named World's Best Bank for Emerging Markets in 2024
14/08/202406:57PR Newswire (US)Bybit Report Suggests Bitcoin Rally Could Extend: Insights from BlockScholes
14/08/202406:56Business WireInvesting in the Future: Gesa Credit Union Backs Nymbus to Drive Sustainable Growth
14/08/202406:55GlobeNewswire Inc.JetBlue Announces Pricing of $2,000 Million Senior Secured Notes Offering and $765 Million Term LoanNASDAQ:JBLUJetBlue Airways Corporation
14/08/202406:52PR Newswire (US)Florida Builders Liquidations Auction: 22 Properties, Bids Starting at $95,000
14/08/202406:51Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:FEDUFour Seasons Education Cayman Inc
14/08/202406:49Alliance NewsAlliance NewsAmaroq swings to loss but says Nalunaq "advancing smoothly"LSE:AMRQAmaroq Minerals Ltd.
14/08/202406:45Business WireILWU FCU and Columbine FCU Launch Mahalo’s Thoughtful Banking® Platform
14/08/202406:45GlobeNewswire Inc.Fairfax Announces Acquisition of Additional Ensign Energy Services Inc. Common SharesTSX:FFH.UFairfax Financial Holdings Limited
14/08/202406:45GlobeNewswire Inc.Clearlight’s Countdown to Wellness—Gifts That Shine Bright This Holiday Season
14/08/202406:45Business WireHewlett Packard Enterprise to Present Live Audio Webcast of Fiscal 2024 Third Quarter Earnings Conference CallNYSE:HPEHewlett Packard Enterprise Company

Su Consulta Reciente

COIN
AVAXUSD
Avalanche
FX
USDMXN
US Dollar vs MXN
COIN
XRPUSD
Ripple
CCOM
OILBRENT
Brent Oil
COIN
ETHUSD
Ethereum
NYSE
JPM
JP Morgan Chase
COIN
BTCUSD
Bitcoin
COIN
ADAUSD
Cardano
USOTC
RHHBY
Roche (QX)
NYSE
CVX
Chevron
NASDAQ
AAPL
Apple
NYSE
MCD
McDonalds
AMEX
SPY
SPDR S&P 500
NYSE
AXP
American Express
NASDAQ
QQQ
Invesco QQQ Trust Series 1
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados